TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 59 filers reported holding TANGO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,038,359 | +239.2% | 19,363,975 | 0.0% | 82.15% | +41.4% |
| Q2 2023 | $64,288,397 | -15.9% | 19,363,975 | 0.0% | 58.09% | +6.3% |
| Q1 2023 | $76,487,701 | -45.5% | 19,363,975 | 0.0% | 54.67% | -8.4% |
| Q4 2022 | $140,388,819 | +100.3% | 19,363,975 | 0.0% | 59.70% | +45.7% |
| Q3 2022 | $70,098,000 | -20.1% | 19,363,975 | 0.0% | 40.96% | -29.0% |
| Q2 2022 | $87,719,000 | -40.2% | 19,363,975 | 0.0% | 57.68% | +7.3% |
| Q1 2022 | $146,779,000 | -30.7% | 19,363,975 | 0.0% | 53.77% | -11.7% |
| Q4 2021 | $211,842,000 | -15.4% | 19,363,975 | 0.0% | 60.92% | +7.2% |
| Q3 2021 | $250,376,000 | – | 19,363,975 | – | 56.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |